Dissertations / Theses on the topic 'Myotonia; Muscle'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 36 dissertations / theses for your research on the topic 'Myotonia; Muscle.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
Papponen, H. (Hinni). "The muscle specific chloride channel ClC-1 and myotonia congenita in Northern Finland." Doctoral thesis, University of Oulu, 2008. http://urn.fi/urn:isbn:9789514286926.
Full textTiivistelmä Lihasspesifisen kloridikanavan ClC-1:n toiminnalliset virheet johtavat alentuneeseen kloridin johtumiseen solukalvon läpi ja lihassolun ylieksitoitumiseen. Tämän seurauksena lihaksen rentoutuminen vaikeutuu ja havaitaan myotoniaa, lihasjäykkyyttä. Pohjoissuomalaisesta potilasmateriaalista tautiin johtavia geenimutaatioita löytyi kolme erilaista. Poikkeuksellista havainnoissa on erilaisten mutaatioiden vähyys, mikä on tyypillistä suomalaiselle tautiperinnölle. Yhteensä tämän kloridikanavan mutaatioita on julkaistu yli 80 erilaista. Tutkiessamme normaalin ja mutatoidun ClC-1 lRNA:n ja proteiinin käyttäytymistä ja sijaintia lihassoluviljelmissä. Havaitsimme eron lihasleikkeiden ja eristettyjen myofiibereiden välillä. Lihasleikkeissä ClC-1 paikantui solun pinnalle sarkolemmalle, mutta eristetyissä myofiibereissä lähinnä solun sisälle. Stimuloimalla eristettyjä myofiibereitä sähkövirralla tai käsittelemällä proteiini kinaasi C inhibiittorilla, saimme kloridikanava-proteiinin siirtymään takaisin solun pinnalle. Proteiinitasolla kuljetuksessa on havaittavissa eroja. Aminohappomuutokseen johtavat pistemutaatiot aiheuttivat proteiinin jäämisen endoplasmiseen kalvostoon, kun taas ennenaikaisen stop-kodonin johdosta lyhentynyt proteiini kuljetetaan eteenpäin Golgin laitteeseen. Myotuubeissa tämä lyhentynyt proteiini kuitenkin hajotettiin nopeammin kuin normaali kloridikanavaproteiini. Sekä kuljetuksen hidastuminen että nopeampi hajotus johtavat tilanteeseen, jossa lihassolun solukalvolla on liian vähän kloridikanavia ylläpitämään lihaksen normaalia fysiologista toimintaa. Monitumaisten lihassolujen laaduntarkkailu havaittiin vielä monitahoisemmaksi kuin yksitumaisilla. Monitumainen lihassolu on riippuvainen hermoärsytyksestä ja lihasaktiivisuudesta. Lisäksi fosforylaatioon liittyvä signalointi on tärkeää ClC-1 proteiinin oikealle paikantumiselle lihassolussa
Chaiklieng, Sunisa. "Low chloride conductance myotonia - in vitro investigations on muscle stiffness and the warm-up phenomenon." [S.l. : s.n.], 2008. http://nbn-resolving.de/urn:nbn:de:bsz:289-vts-61365.
Full textHawash, Ahmed Alaa. "Persistent Inward Currents Play a Role in Muscle Dysfunction Seen inMyotonia Congenita." Wright State University / OhioLINK, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=wright1500932300888521.
Full textFialho, D. "Clinical, genetic and electrophysiological study of skeletal muscle channelopathies : new insights into myotonia congenita and Andersen-Tawil syndrome." Thesis, University College London (University of London), 2009. http://discovery.ucl.ac.uk/18909/.
Full textStorbeck, Christopher J. "Effects of the myotonic dystrophy mutation in muscle differentiation and apoptosis." Thesis, University of Ottawa (Canada), 2002. http://hdl.handle.net/10393/6194.
Full textMatloka, Magdalena. "MBNL derivatives for therapeutic application in myotonic dystrophy." Electronic Thesis or Diss., Sorbonne université, 2019. https://accesdistant.sorbonne-universite.fr/login?url=https://theses-intra.sorbonne-universite.fr/2019SORUS269.pdf.
Full textMyotonic dystrophy (DM) is an autosomal neuromuscular disease encompassing two distinct forms, type 1 (DM1) and type 2 (DM2), which are caused by abnormal microsatellite expansions of C(C)TG repeats in the 3’UTR of the DMPK and first intron of ZNF9 genes, respectively. Mutant RNAs carrying expanded repeats are retained in the nucleus as riboprotein aggregates that abnormally sequester MBNL splicing factors leading to alternative splicing misregulations associated with clinical symptoms. Although various therapeutic approaches for DM are under development, there is no effective therapy available so far. In this study, we designed a novel gene therapy strategy with the use of an engineered MBNL RNA-binding protein derivative that acts as a CUGexp-decoy to release sequestered endogenous MBNL factors and restore their proper functions. Expression of the decoy results in the correction of DM1-associated features in both in vitro and in vivo models of the disease. Subsequent optimization processes were applied to the engineered decoy and the most potent derivate that increases its functional capacity was selected for further therapeutic application. Additionally, we developed an autoregulatory system based on a splice-sensor strategy to control transgene product expression and provided a proof-of-concept of its efficacy in both in vitro and in vivo systems. In conclusion, my work establishes the potency of gene therapy treatment for DM and support the use of the decoy-based approach as an alternate or complementary therapeutic intervention for DM
Palada, Vinko [Verfasser]. "Molecular mechanisms of muscle pain associated with myotonic dystrophy type II / Vinko Palada." Berlin : Freie Universität Berlin, 2017. http://d-nb.info/1128150751/34.
Full textKiosses, Theodore. "DNA binding specificity and transcriptional regulation of Six4 : a myotonic dystrophy associated transcription factor." Thesis, University of Edinburgh, 2009. http://hdl.handle.net/1842/3948.
Full textWhiting, Elisabeth J. "Localization of the myotonic dystrophy kinase in human and rodent muscle and central nervous tissue." Thesis, University of Ottawa (Canada), 1995. http://hdl.handle.net/10393/9986.
Full textYAMAMOTO, SHUHEI. "Evaluation of Skeletal Muscle with Thallium-201 Scintigraphy in Myotonic Muscular Dystrophy: A Case Report." Nagoya University School of Medicine, 1987. http://hdl.handle.net/2237/17494.
Full textWei, Christina. "The Role of GSK3ß-CUGBP1 Pathway in the Correction of Myotonic Dystrophy Type 1 Muscle Pathology." University of Cincinnati / OhioLINK, 2016. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1490350842490709.
Full textDe, Dea Diniz Damily. "The study of the consequences of serca1’s missplicing on muscle function in myotonic dystrophy type 1." Electronic Thesis or Diss., Sorbonne université, 2018. http://www.theses.fr/2018SORUS569.
Full textMyotonic Dystrophy Type 1 (DM1) is a neuromuscular disease that affects mainly the skeletal muscle with the presence of myotonia and progressive atrophy and is caused by abnormal CTG expansion in the 3'UTR of the DMPK gene. The expression of the mutated RNA induces the loss of function of the MBNL1 splicing factor and leads to the re-expression of fetal isoforms of certain transcripts in the adult tissues of DM1 patients. In order to identify new mechanisms involved in muscle dysfunction, I developed a model of muscle cells conditionally expressing 960 interrupted CTG repeats. Following the targeted expression of RNA-960CUG in myotubes, transcriptome analysis shows that despite the presence of functions/biological processes typical of DM1, the induction of non-DM1 associated pathways and the absence of phenotype suggest that this model is not appropriate for this study of molecular mechanisms. I also did a study of the impact of the ATP2A1 (SERCA1) misplicing, present in DM1 patients, on the muscular function. I used an antisense approach to promote the exclusion of exon 22 from Atp2a1 in the muscle of two animal models, leading to the reexpression of the Serca1b fetal isoform. The re-expression of Serca1b in the muscle of adult wild-type mice leads to a slowing contraction and a loss of muscle mass. In zebrafish, this modification on Atp2a1 splicing causes an alteration on the locomotion. All of these results indicate that reexpression of Serca1b affects muscle function and may contribute to muscle symptoms in DM1
Beaulieu, Daniel. "Inhibition de la différenciation myogénique par un facteur soluble sécrété par des myoblastes dérivés de muscules squelettiques de sujets atteints de la dystrophie myotonique de type 1." Master's thesis, Université Laval, 2006. http://hdl.handle.net/20.500.11794/18661.
Full textMyotonic dystrophy (DM1), the most common form of inherited neuromuscular disease in adults, affects 1 in 8000 individuals worldwide. DM1 is an autosomal dominant muscular dystrophy with very variable symptom presentations. Adult onset DM1 is primarily characterized by myotonia, muscle wasting and weakness, but also affects a number of organs and tissues. One characteristic of the disease is the presence of a severe congenital form (CDM1), which differs from the adult form. CDM1 is characterized by a delay in the development of skeletal muscles. This form is associated with hypotonia, respiratory complications and mental retardation. DM1 is caused by the expansion of an unstable CTG trinucleotide repeat in the 3’untranslated region of the myotonic dystrophy protein kinase (DMPK) gene. To date, the mechanisms by which the DM1 mutation affects skeletal muscles development or regeneration are unknown. A previous study demonstrated that serum produced by mothers of children with congenital myotonic dystrophy inhibits myogenic differentiation. In this study, we hypothesized that CDM1 myoblasts secrete a soluble factor that blocks myogenic differentiation. We provide evidence that this soluble factor is produced by DM1 and CDM1 myoblasts which may be involved in their deficiency to fuse. The inhibitory effect is proportional to the length of the CTG repeat expansion. In addition, the delay in muscle differentiation is associated with a specific reduction in myogenin gene expression. We believe that the DM1 mutation triggers the expression of a soluble factor, which is able to block myogenic differentiation. The identification of this soluble factor is presently under investigation.
Gervais, Hélène Vial Christophe. "Canalopathies musculaires." Créteil : Université de Paris-Val-de-Marne, 2005. http://doxa.scd.univ-paris12.fr:80/theses/th0235200.pdf.
Full textCrawford, Parks Tara. "Novel Functions for the RNA-binding Protein Staufen1 in Skeletal Muscle Biology and Disease." Thesis, Université d'Ottawa / University of Ottawa, 2016. http://hdl.handle.net/10393/35627.
Full textLienhart, Valérie. "Les protéines impliquées dans les myopathies à centralisation des noyaux : comprendre leur lien et les conséquences de leurs mutations." Strasbourg, 2011. http://www.theses.fr/2011STRA6200.
Full textIntroduction : Centronuclear Myopathies (CNM) are rare congenital diseases characterized by muscle weakness and muscular fibers with abnormal central nuclei. There are three different forms : the X-linked form XLCNM (mutations in MTM1), the autosomal dominant form ADCNM (mutations in DNM2) and the autosomal recessive form ARCNM (mutations in BIN1). Corresponding proteins are respectively myotubularin (a phosphoinositides phosphatases), dynamin 2 (a large GTPase), and amphiphysine 2/BIN1 ( a protein involved in membranes remodeling). A functional connection between these three proteins is suggested by their implication in membrane trafficking and membrane remodeling. Results : a new method of genetic diagnosis by western-blot in XLCNM has been developed. This method shows a near-total diminution of the MTM1 concentration. A functional study of BIN1 mutations shows that these mutations are responsible either of membrane tubulation diminutions or an abnormal 3D conformation of BIN1. This misconformation could corrupt the recruitment of DNM2. A collaboration with Dr N. Charlet-Berguerand team demonstrates that the abnormal splicing of BIN1 exon 11 is responsible of a defect of membrane tubulation function in muscular cells of dystrophic patients. Finally, experiences of protein interaction show that MTM1 and BIN1 are able to interact together directly via the SH3 domain of BIN1. Conclusion : all these data suggest that these 3 proteins are involved in a same pathway in the skeletal muscle. This pathway could be linked with the formation/maintenance of T-tubules
Roussel, Marie-Pier. "Adaptations du muscle squelettique induites par l'entraînement physique en résistance, aigu et chronique, chez les patients atteints de dystrophie myotonique de type 1." Thèse, Université Laval, 2017. http://constellation.uqac.ca/4446/1/Roussel_uqac_0862N_10399.pdf.
Full textZhao, Juan. "Biophysical characterization of neuronal and skeletal muscle sodium channels, and their regulation by auxiliary beta subunits." Thesis, Université Laval, 2012. http://www.theses.ulaval.ca/2012/28793/28793.pdf.
Full textVoltage-gated Na channels are responsible for the rising phase of action potentials, and consist of a pore-forming α subunit and one or more auxiliary β subunits. The α subunit alone is sufficient for the functional expression of Na channels, however, β subunits modulate the location, expression and functional properties of α subunits. My thesis will focus on three neuronal Na channels (Nav1.6, Nav1.7 and Nav1.8) and one skeletal muscle Na channel (Nav1.4). Neuronal Na channel are key players in the impulse propagation along axon. Nav1.7 and Nav1.8 are the main Na channels expressed in DRG neurons, and their altered expression and modulation following injury and inflammation play a major role in nociception and chronic pain. Nav1.6 is highly concentrated at nodes of Ranvier, and has a critical role not only in saltatory conduction but also in high-frequency repetitive firing. Skeletal muscle Na channel Nav1.4 is the initiator of muscle contraction. Mutations in Nav1.4 cause skeletal muscle channelopathies. Guiding questions for our investigations were: 1) How do auxiliary β subunits regulate peripheral nerve Na channel Nav1.6 and Nav1.8? 2) What is the underlying biophysical defect of M1476I, a novel founder SCN4A mutation associated with painful cold-induced myotonia in French Canadians? 3) What is the biophysical characterization of the Nav1.6 persistent current? 4) What is the expression pattern of auxiliary subunits, and how do β subunits regulate Nav1.7 in DRG neurons? We addressed these questions by multiple approaches including patch clamp techniques for whole-cell and single-channel recordings in heterologous expression systems; immunohistochemistry, single-cell RT-PCR and immunoprecipitation in DRG neurons. Firstly, we employed single-cell RT-PCR of acutely dissociated DRG neurons to identify the expression of β1-4 subunits in small-diameter sensory neurons. Our results indicated that small-diameter DRG neurons widely expressed Nav1.6 and Nav1.8 channels and β1-β3 subunits. Co-expression studies were used to assess the regulation of Nav1.6 and Nav1.8 by β subunits. The β1 subunit induced a significant increase in the current density of Nav1.8 when co-expressed in HEK293 cells, but had no effect on that of Nav1.6. In addition, the C-terminal domain of β1 was involved in the modulation of Nav1.8 channel based on the results of experiments with β1/β2 chimeras harboring various regions of the strongly regulating β1 together with the weakly regulating β2 subunit. Secondly, we investigated the biophysical defects of M1476I mutation in Nav1.4 channels using whole-cell patch-clamp technique in tsA201 cells. M1476I mutant channel exhibited similar biophysical defects compared with other PAM-causing mutations, including an increased persistent current of Nav1.4, a slower current decay, a positive shift of fast inactivation, and an accelerated recovery from fast inactivation. Lowering the temperature slowed the kinetics for both wide-type and mutant channels, and worsened the defective fast inactivation of M1476I channels by further increasing the amplitude of the persistent current. Mexiletine helps relieve myotonia in M1476I carriers by effectively suppressing the increased persistent current, except for the use-dependent block. However, mexiletine had a reduced effectiveness on the use-dependent block of M1476I channels, and that was associated with a faster recovery from mexiletine block of mutant channels. Thirdly, we characterized the whole-cell and single-channel properties of Nav1.6 persistent currents expressed in HEK293 cells. We noted that Nav1.6 persistent current was highly sensitive to the composition of the internal solution, and persistent current was rarely detectable when CsF instead of CsCl was used. By substituting CsF for CsCl in the intracellular solution, we showed that Nav1.6 persistent current in the whole-cell configuration was 3–5% of the peak transient current. This amplitude of persistent current was similar to the ratio between peak and persistent open probability observed in the single-channel recording, indicating that the occurrence of late channel reopenings accounts for the persistent macroscopic Na current typical of Nav1.6. Finally, we employed a combination of single-cell RT-PCR, immunocytochemistry and immunoprecipitation to investigate subunit expression in subpopulations of sensory neurons. subunits were differentially expressed in small (2, 3) and large (1, 2) DRG neurons. Nav1.7 mRNA was significantly co-expressed with the 2 and 3 subunits in the same population of small-diameter DRG neurons. They formed stable protein-protein interactions and co-localized within the plasma membranes of neurons.When co-expressed in HEK293 cells, 3 and 1 subunits shifted activation and inactivation curves respectively and induced a marked increase in Nav1.7 window current. Our data indicated a preferential expression of subunits in small and large DRG neurons and a subunit-specific Nav1.7 regulation in these subpopulations of sensory neurons.
Tableau d'honneur de la FÉSP
Baker, Keren Julie. "Effects of peptide toxins on the Ca'2'+-ATPase of sarcoplasmic reticulum." Thesis, University of Southampton, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.296260.
Full textPicchio, Lucie. "Mise en place, caractérisation phénotypique et transcriptomique d'un modèle de Drosophilie de la Dystrophie Myotonique de type 1." Thesis, Clermont-Ferrand 1, 2013. http://www.theses.fr/2013CLF1MM15/document.
Full textMyotonic Dystrophy Type 1 (DM1) or Steinert's disease is the most common genetic neuromuscular disorder affecting 1 out of 8000 people worldwide. This multisystemic disease affects particularly the skeletal muscles (myotonia, muscle weakness and wasting) and the heart, which can exhibit various symptoms like conduction disturbances and arrhythmia (auricular fibrillation and flutter). DM1 is caused by an unstable CTG repeat expansion in the 3' non-translated region of the DMPK gene. In healthy individuals, the number of CTG repeats ranges from 5 to 37 whereas DM1 patients carry from 50 to thousands repeats. It is well established that when expanded non-coding repeats aggregate into foci within muscle nuclei and sequester the MBNL1 splicing factor. However, the involvement of the stabilization and accumulation of CUGBP1 following PKC hyper-phosphorylation in the disease is a controversial matter in the DM1 community. Lately, in addition to the disruption of the balance between MBNL1/CUGBP1, several mechanisms were identified as part of the DM1 pathogenesis. Among them, transcription factors perturbations, altered maturation of miRNA, kinases activation… each of them leading eventually to transcriptomic alterations. In order to investigate the effect of toxic repeat expression on phenotypic and transcriptomic alterations, we generated three inducible site-specific Drosophila lines expressing 240, 600 and 960 triplet repeats. We worked in parallel on a mbl (MBNL1 orthologue) knocked-down line and two bru-3 (CUGBP1 orthologue) gain of function lines. When expressed in somatic muscles, CTG repeats lead to altered motility, fiber splitting, reduced fiber size and affected myoblast fusion process in a Mbl and Bru-3 dependent manner. In addition, toxic repeats cause fiber hyper-contraction in a Mbldependentmanner due to dSERCA mis-splicing. Comparative transcriptional profiling performed on larval muscles of different conditions show that mbl attenuation reproduces 70-82% of DM1 transcriptomic deregulations whereas bru-3 gain of function represents 32-53% of transcritomic alterations. Thus Mbl appears as a key factor of transcripts deregulations observed in DM1 muscles. On the contrary, physiologic analyses performed on adult hearts suggest that Bru-3 is a key factor for cardiac phenotypes. Indeed, on one hand, mbl attenuated flies display dilated cardiomyopathy, a symptom barely diagnosed in patients. On the other hand, bru-3 gain of function line and DM1 lines display fibrillation, which evolves withage or repeat size into a phenotype reminiscent of heart insufficiency in patients
Caron, Solenne. "Transplantation de myoblastes génétiquement modifiés de patients atteints de dystrophie myotonique dans le muscle de souris." Thesis, Université Laval, 2008. http://www.theses.ulaval.ca/2008/25168/25168.pdf.
Full textMastroyiannopoulos, Nikolaos. "Woodchuck post-transcriptional element induces nuclear export of myotonic dystrophy 3' untranslated region transcripts and mediate the repair of muscle cell differentiation." Thesis, University of Bristol, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.500394.
Full textSantos, Adriano Silvio dos. "efeito do laser de baixa potência sobre células musculares c2c12 submetidas à lesão por miotoxinas BTHTX - I e BTHTX - II isoladas do veneno da serpente bothrops jararacussu." Universidade Nove de Julho, 2015. http://bibliotecadigital.uninove.br/handle/tede/1296.
Full textMade available in DSpace on 2016-05-17T20:16:41Z (GMT). No. of bitstreams: 1 Adriano Silvio dos Santos.pdf: 1418434 bytes, checksum: 4ac5ef78eb225e6693c107993f6ee978 (MD5) Previous issue date: 2015-02-24
Snakes venom of the Bothrops species induces a local inflammatory reaction, characterized by pain, edema, leukocyte migration and can be accompanied by tissue necrosis. The use of antivenom performs the function of neutralizing the greatest possible amount of circulating venom, thus minimizing its systemic effects, but its action does not extend to local manifestations, and thus require the use of another therapeutic option to control this reaction. The low level laser therapy (LLLT) is used as an alternative treatment in cases of muscle injury due to its biological effects, such as analgesics, anitinflamatory and healing. In a previous study of our lab it was found that LBP can enhance the viability of C2C12 muscle cells after the addition of B. jararacussu venom in the medium and that this effect of LBP is related to protection of the cell membrane. In the present study we analyzed the effect of LBP in the cell monolayer integrity, viability of muscle cells, exposed to injury by myotoxins BthTX - I - and BthTX - II isolated from Bothrops jararacussu venom. Cells received BthTX – I (75 μg / mL) and were immediately irradiated with LLLT Aluminum Indium Gallium Phosphate and Aluminium Gallium Arsenide, the wavelengths (λ) 685nm and 830 nm, power density 4 J/cm2, 100mW of power, total energy 1,3 J, application time of 13 and 35 seconds per point and the cells were incubated for 15, 30 and 60 minutes. The results demonstrated that BthTX – I affect cell viability in a dose dependent manner, but did not change cell integrity. The concentration of 75 μg/mL was chosen for the experiments with LBP. LLLT caused an significant increase in cell viability in all the analyzed period of time and in the λ 685 nm and 830 nm against Bothrops I toxin, however in the LBP λ 685 nm against Bothrops toxin II was effective only at 15 min, while the LBP at λ 830 was effective at 15 and 60 min. The LLLT was not able to change the LDH release at all times and wavelength used. Thus, LBP was able to protect C2C12 muscle cells against the miotoxic effect of isolated myotoxins isolated from B. jararacussu venom. Therefore, the results suggest that LLLT can be considered an effective therapeutic tool in patients bitten by snakes.
O veneno das serpentes do gênero Bothrops induz uma reação inflamatória local intensa, caracterizada por dor, formação de edema, migração leucocitária, podendo ser acompanhada por necrose tecidual. A utilização do soro antibotrópico desempenha a função de neutralizar a maior quantidade possível do veneno circulante, minimizando assim seus efeitos sistêmicos, porém sua ação não se estende às manifestações locais, sendo assim necessário o uso de outro recurso terapêutico para o controle dessa manifestação. A laserterapia de baixa potência (LBP) é uma alternativa de tratamento em situações de lesão muscular, devido a seus efeitos biológicos, tais como analgésicos, antinflamatórios e cicatrizantes. Em trabalhos anteriores realizados em nosso laboratório, verificou-se que o LBP foi capaz de aumentar a viabilidade de células musculares C2C12, após a adição do veneno de B. jararacussu e que esse efeito do LBP é relacionado a uma proteção da membrana celular. Assim, o objetivo deste trabalho foi analisar o efeito do LBP em células musculares C2C12 submetidas à lesão por miotoxinas (BthTX - I e BthTX - II) isoladas do veneno da serpente Bothrops jararacussu quanto a: viabilidade, descolamento celular e liberação da enzima LDH. As células receberam a BthTX – I e BthTX – II na dose 75 μg/mL e foram imediatamente irradiadas com LBP Índio Gálio Alumínio Fósforo e Arseneto de Gálio Alumínio, nos comprimentos de onda (λ) 685 nm vermelho e 830 nm infra-vermelho, de forma pontual, tempo de aplicação de 13 s e 35 s respectivamente e as células foram incubadas por 15, 30 e 60 minutos. Os resultados demonstraram que a BthTX - I e BthTX - II afetou a viabilidade celular de forma dose-dependente, sendo escolhida a dose 75 μg/mL para a realização dos experimentos com o LBP, porém não foi capaz de causar alterações na integridade. O LBP causou aumento significativo na viabilidade celular, em todos os tempos analisados no λ 685 nm e 830 nm frente à BthTX - I, entretanto o LBP no λ 685 nm e λ 830 frente a BthTX - II foi efetivo somente no tempo de 15 e 60. O LBP não foi capaz de diminuir a liberação de LDH em todos os tempos analisados e com os dois λ utilizados. Desta forma, verificou-se que o LBP foi capaz de proteger as células musculares C2C12 contra o efeito miotóxico das miotoxinas isoladas do veneno B. jararacussu e que esta proteção está relacionada ao efeito protetor a nível mitocondrial. Ainda, os resultados obtidos sugerem que o LBP pode ser considerado uma ferramenta terapêutica eficaz em pacientes picados por serpentes.
Carle, Thomas. "Physiopathologie moléculaire de canalopathies sodiques du muscle squelettique : conséquences biophysiques des mutations R1132Q et Q270K responsables respectivement de paralysie périodique hypokaliémique et de paramyotonie congénitale." Paris 6, 2009. http://www.theses.fr/2009PA066374.
Full textNey, Michel. "Rôle de l'inclusion de l'exon 7 de BIN1 dans la faiblesse musculaire des patients atteints de dystrophie myotonique." Thesis, Strasbourg, 2016. http://www.theses.fr/2016STRAJ077/document.
Full textMyotonic dystrophy of type 1 (DM1), is an inherited genetic disease affecting around 1 in 8000 person. Patients suffering from DM1 develop essentially muscle disorders such as muscle weakness, muscle loss and atrophy. The cause of DM1 is explained by the mutation of a gene called “DMPK“.During my thesis, I discovered that the alternative splicing of BIN1 mRNA was altered in the muscle of DM1 patients. Indeed, the BIN1 exon 7, which is normally absent in healthy muscle, is aberrantly expressed in DM1 muscle. By using a mouse model, I found that the forced expression of BIN1 exon 7 was responsible of the alteration of both muscle structure and function. Notably, we found a decrease in muscle fibers area (atrophy) and an increase of muscle weakness, compared to wild-type mice. Therefore, this work will help in the understanding of the disease mechanism and could explain the causes of muscle weakness and atrophy, which have never been elucidated to this date
Polay, Espinoza Micaela. "Fonctions moléculaires des hélicases ARN DDX5 et DDX17 dans la biologie du muscle dans un contexte sain et pathologique." Phd thesis, Université Claude Bernard - Lyon I, 2014. http://tel.archives-ouvertes.fr/tel-00988051.
Full textPetitclerc, Émilie. "Association entre le profil de force musculaire et les capacités fonctionnelles aux membres inférieurs chez les personnes atteintes des phénotypes adulte classique et adulte tardif de dystrophie myotonique de type 1." Mémoire, Université de Sherbrooke, 2015. http://hdl.handle.net/11143/8031.
Full textAbstract: Purpose: The purposes of this study were 1) to describe lower limbs muscle strength and mobility capacities, and 2) to explore the respective contribution of lower limb muscle weaknesses on mobility in the adult and late-onset phenotypes of myotonic dystrophy type 1 (DM1). Methods: This study is a secondary analysis of part of the results of a larger study, whose purpose was to identify social participation and quality-of-life determinants in 200 DM1 patients (158 adult and 42 late-onset). The strength of four lower limb muscle groups was assessed using manual muscle testing (MMT) and handheld dynamometry quantitative muscle testing (QMT). Mobility capacities were assessed using standardized tests (Berg balance scale, 10 Meter Walk Test and Timed Up & Go). Results: Although the late-onset phenotype showed less weaknesses and mobility limitations than the adult phenotype (p <0.001-0.020), and although MMT showed no weakness in the late-onset phenotype, quantitative strength losses of 12-20% were measured in this phenotype, with the exception of the knee flexors. These weaknesses led to mobility limitations in 22-48% of participants with the late-onset phenotype. In the adult phenotype, muscle strength impairment was slightly more important distally than proximally (2-2.5/10 and 5.8-8.2% for MMT and QMT, respectively) (p <0.001-0.002). According to those results, the adult and late-onset phenotypes show different profiles of lower limb impairment, and should not be pooled for data analysis. A general progression of quantitative muscle weakness and of mobility scores was observed according to the Muscular Impairment Rating Scale (MIRS) classification. Quantitative weaknesses, with the exception of the knee flexors, and mobility limitations were observed from the first MIRS grades. QMT is therefore definitely a more effective tool for measuring weakness in DM1. Finally, ankle dorsiflexors and knee extensors seem to be good indicators of lower limb function in DM1. Conclusion: This study allowed a better characterization of lower limb weaknesses and mobility limitations in the adult and late-onset phenotypes of DM1, and explored the contribution of lower limb weaknesses on mobility capacities in this population. These results will be useful for developing more specific rehabilitation programs and for optimizing the evaluation of these impairments in the context of the upcoming therapeutic trials. Keywords: Myotonic dystrophy type 1, phenotypes, muscle strength, mobility capacities, lower limbs, explanatory variables, physiotherapy.
Ara?jo, Thaise Lucena. "For?a muscular respirat?ria, qualidade de vida e modula??o auton?mica da frequ?ncia card?aca na distrofia miot?nica." Universidade Federal do Rio Grande do Norte, 2009. http://repositorio.ufrn.br:8080/jspui/handle/123456789/16675.
Full textBackground: The myotonic dystrophy (MD) is a multisystem neuromuscular disease that can affect the respiratory muscles and heart function, and cause impairment in quality of life. Objectives: Investigate the changes in respiratory muscle strength, health-related quality of life (HRQoL) and autonomic modulation heart rate (HR) in patients with MD. Methods: Twenty-three patients performed assessment of pulmonary function, sniff nasal inspiratory pressure (SNIP), the maximal inspiratory (MIP) and expiratory (MEP) pressure, and of HRQoL (SF-36 questionnaire). Of these patients, 17 underwent assessment of heart rate variability (HRV) at rest, in the supine and seated positions. Results: The values of respiratory muscle strength were 64, 70 and 80% of predicted for MEP, MIP, and SNIP, respectively. Significant differences were found in the SF-36 domains of physical functioning (58.7 ? 31,4 vs. 84.5 ? 23, p<0.01) and physical problems (43.4 ? 35.2 vs. 81.2 ? 34, p<0.001) when patients were compared with the reference values. Single linear regression analysis demonstrated that MIP explains 29% of the variance in physical functioning, 18% of physical problems and 20% of vitality. The HRV showed that from supine position to seated, HF decreased (0.43 x 0.30), and LF (0.57 x 0.70) and the LF/HF ratio (1.28 x 2.22) increased (p< 0.05). Compared to healthy persons, LF was lower in both male patients (2.68 x 2.99) and women (2.31 x 2.79) (p< 0.05). LF / HF ratio and LF were higher in men (5.52 x 1.5 and 0.8 x 0.6, p <0.05) and AF in women (0.43 x 0.21) (p< 0.05). There was positive correlation between the time of diagnosis and LF / HF ratio (r = 0.7, p <0.01). Conclusions: The expiratory muscle strength was reduced. The HRQoL was more impaired on the physical aspects and partly influenced by changes in inspiratory muscle strength. The HRV showed that may be sympathetic dysfunction in autonomic modulation of HR, although with normal adjustment of autonomic modulation during the change of posture. The parasympathetic modulation is higher in female patients and sympathetic tends to increase in patients with longer diagnosis
Introdu??o: A distrofia miot?nica (DM) ? uma doen?a neuromuscular multissist?mica que pode afetar a musculatura respirat?ria e a fun??o card?aca, e ocasionar preju?zos na qualidade de vida. Objetivos: Investigar as altera??es na for?a muscular respirat?ria, qualidade de vida relacionada ? sa?de (QVRS), e modula??o auton?mica da freq??ncia card?aca (FC) em pacientes com DM. M?todos: Foram avaliados 23 pacientes quanto ? fun??o pulmonar, press?o inspirat?ria nasal sniff (SNIP), press?es respirat?rias m?ximas (PIm?x e PEm?x), e QVRS (question?rio SF-36). Destes, 17 realizaram avalia??o da variabilidade da frequ?ncia card?aca (VFC) em repouso, nas posturas supina e sentada. Resultados: Os valores da for?a muscular respirat?ria foram de 64, 70 e 80%predito para PEm?x, PIm?x, e SNIP, respectivamente. Foi encontrada diminui??o significativa nos dom?nios do SF-36 capacidade funcional (58.7 ? 31,4 vs. 84.5 ? 23, p<0.01) e disfun??o f?sica (43.4 ? 35.2 vs. 81.2 ? 34, p<0.001) comparado a valores de refer?ncia. A an?lise de regress?o linear mostrou que a PIm?x explica 29% da vari?ncia na capacidade funcional, 18% na disfun??o f?sica e 20% na vitalidade. A VFC mostrou que, da postura supina para a sentada, o espectro AF diminuiu (0.43 x 0.30) e o espectro BF (0.57 x 0.70) e a raz?o BF/AF (1.28 x 2.22) aumentaram, com p<0.05. Comparado a valores de refer?ncia, BF foi inferior (p<0.05) tanto nos pacientes homens (2.68 x 2.99), como nas mulheres (2.31 x 2.79). A raz?o BF/AF e o espectro BF foram maiores nos homens (5.52 x 1.5 e 0.8 x 0.6), e o espectro AF, nas mulheres (0.43 x 0.21), com p<0.05. Houve correla??o significativa positiva entre tempo de diagn?stico e raz?o BF/AF (r= 0.7, p< 0.01). Conclus?es: Indiv?duos com DM t?m for?a muscular expirat?ria diminu?da. A QVRS mostrou-se mais prejudicada em rela??o a aspectos f?sicos e parcialmente influenciada por varia??es na for?a muscular inspirat?ria. Pode haver disfun??o simp?tica na modula??o auton?mica da FC, com ajuste normal da postura supina para a sentada. A modula??o parassimp?tica ? superior em pacientes mulheres e a modula??o simp?tica tende a aumentar nos pacientes com maior tempo de diagn?stico
Wen-Sheng and 蔡文盛. "The effect of potassium channel openers on the myotonia of mouse skeletal muscle." Thesis, 2012. http://ndltd.ncl.edu.tw/handle/41693856640680381038.
Full text中山醫學大學
生物醫學科學學系碩士班
100
The purpose of this study was to investigate the effect of KCNQ (potassium channel, voltage-gated, KQT-like subfamily) openers in preventing myotonia caused by anthracene-9-carboxylic acid (9-AC, a chloride channel blocker). Myotonia is a neuromuscular disorder and characterized by the membrane hyperexcitability and slow relaxation of muscles after a contraction. An animal model of myotonia can be elicited in murine skeletal muscle by 9-AC treatment. Retigabine, flupirtine and lidocaine can inhibit the increased twitch amplitude (0.1 Hz stimulation) and reduce the tetanic fade (20 Hz stimulations) observed in the presence of 9-AC. Furthermore, the prolonged twitch duration of skeletal muscle was also inhibited by retigabine, flupirtine or lidocaine. Lamotrigine (an anticonvulsant drug) has a lesser effect on the muscle twitch amplitude, tetanic fade and prolonged twitch duration as compared with other three medicines. In experiments using intracellular recordings, retigabine and flupirtine clearly reduced the firing frequencies of repetitive action potentials induced by 9-AC. Furthermore, we found that the rising slope of action potentials could not be reduced by the addition of retigabine and flupirtine. These data suggested that KCNQ openers prevent the myotonia induced by 9-AC, at least partly through enhancing potassium conductance in skeletal muscle. Taken together, these results indicate that KCNQ openers are potential alternative therapeutic agents for the treatment of myotonia.
Simpson, Bronwyn Jayne. "Mutagenic and purification studies of the carboxyl tail of ClC-1, the skeletal muscle chloride channel." 2002. http://arrow.unisa.edu.au:8081/1959.8/24999.
Full textthesis (PhDBiomedicalScience)--University of South Australia, 2002.
[Verfasser], Sunisa Chaiklieng. "Low chloride conductance myotonia : in vitro investigations on muscle stiffness and the warm-up phenomenon / submitted by Sunisa Chaiklieng." 2007. http://d-nb.info/997571454/34.
Full textAromataris, Edoardo Claudio. "Pharmacology of the CIC-1 chloride channel." 2009. http://hdl.handle.net/2440/58973.
Full texthttp://proxy.library.adelaide.edu.au/login?url= http://library.adelaide.edu.au/cgi-bin/Pwebrecon.cgi?BBID=1474724
Thesis (Ph.D.) -- University of Adelaide, School of Molecular and Biomedical Science, 2009
Aromataris, Edoardo Claudio. "Pharmacology of the CIC-1 chloride channel." Thesis, 2009. http://hdl.handle.net/2440/58973.
Full textThesis (Ph.D.) -- University of Adelaide, School of Molecular and Biomedical Science, 2009
Wu, Wei-Ping. "A study of the function and structure relationship of the voltage gated skeletal muscle chloride channel, CLC-1." 2003. http://arrow.unisa.edu.au:8081/1959.8/28364.
Full textPhD Doctorate
Caron, Solenne. "Transplantation de myoblastes génétiquement modifiés de patients atteints de dystrophie myotonique dans le muscle de souris /." 2008. http://www.theses.ulaval.ca/2008/25168/25168.pdf.
Full textMateus, Tiago Duarte Cordeiro. "Study of the metabolome and muscle strength measures for the characterization of patients with myotonic dystrophy type 1." Master's thesis, 2021. http://hdl.handle.net/10773/30819.
Full textA distrofia miotônica tipo 1 (DM1) é uma doença hereditária autossómica dominante causada por uma alteração que leva a uma expansão anormal de repetições instáveis de CTG na região 3' não traduzida do gene da proteína quinase da distrofia miotônica (DMPK). DM1 é caracterizado por miotonia, fraqueza muscular distal progressiva e por envolvimento multissistémica, nomeadamente cataratas, dores musculares, disfunções cardíacas e respiratórias, disfunções endócrinas (resistência à insulina, síndrome metabólica, dislipidemia), cancro e alterações no sistema nervoso central (SNC). Doentes com DM1 apresentam frequência de síndrome metabólica maior do que na população geral. Assim, o estudo do metaboloma é de grande importância, pois pode fornecer novos ideias sobre as vias moleculares afetadas nas doenças DM1, bem como discriminar entre os diferentes graus de gravidade em doentes com DM1 e também pode levar ao desenvolvimento de novas terapêuticas metabólicas. Dadas as alterações metabólicas previamente descritas e observadas em doentes com DM1, consideramos que a avaliação do perfil metabólico destes doentes é de grande importância. Portanto, elaborou-se uma revisão da literatura para resumir as alterações metabólicas previamente descritas em doentes com DM1 e a relação da Lipina com as alterações metabólicas na DM1 (Capítulo I). Essencialmente, os estudos anteriores mostraram uma clara alteração metabólica entre os doentes com DM1 e os grupos controlo, nomeadamente o aumento dos níveis de colesterol total, lipoproteína de baixa densidade, triacilglicerol, insulina e resistência HOMA-insulina, o aumento dos níveis de glicose, assim como a diminuição dos níveis de lipoproteína de alta densidade. Esta revisão também demonstrou uma potencial relação entre a Lipina e a sua associação com as anormalidades metabólicas encontradas em doentes com DM1, nomeadamente os papéis metabólicos no tecido adiposo, músculo esquelético, fígado e a sua associação com a dislipidemia e a resistência à insulina, que é uma das características em doentes com DM1. O perfil metabólico dos doentes com DM1 foi então avaliado pela técnica de espectroscopia ATR FTIR, em conjunto com a análise multivariada, sendo que é adequada para fornecer um perfil (bio) químico dos doentes com DM1 e controlos. Essencialmente, fibroblastos derivados de DM1 e controlos foram utilizados, e os resultados demonstraram uma clara discriminação dentro de fibroblastos derivados de DM1 com diferentes repetições de CTG e idades de início da doença, o que significa que estes podem ter um perfil metabólico distinto. Esta discriminação pode ser atribuída principalmente ao metabolismo lipídico alterado na região 1800-1500 cm-1 . Também foi possível discriminar entre os grupos controlo e fibroblastos derivados de DM1 do Instituto Coriell e Centro Hospitalar do Tâmega e Sousa na região de 3000-2800 cm-1 (Capítulo II). Além disso, foi feita uma revisão sistemática para reunir informações de todos os resultados e medidas utilizadas para avaliar a força muscular em doentes adultos com DM1 (Capítulo IV). Foi avaliada a força muscular cardíaca, esquelética e respiratória. Resumidamente, a revisão sistemática demonstrou uma utilização consistente da ecocardiografia, teste muscular quantitativo, teste muscular manual e manometria para avaliar a força muscular cardíaca, esquelética e respiratória. As medidas escolhidas para avaliar a força muscular foram: (1) fração de ejeção para a força do musculo cardíaco; (2) torque isométrico muscular, força de preensão e conselho de pesquisa médica (0-5 pontos e 0-60 pontos) para a força do músculo esquelético; (3) pressão inspiratória máxima e pressão expiratória máxima para a força dos músculos respiratórios. Em conclusão, os resultados sugerem que há uma necessidade de estudos adicionais relativamente ao metabolismo lipídico em doentes com DM1, não apenas para caracterizar melhor estes doentes, como também para compreender o mecanismo subjacente das anormalidades lipídicas e ter novas noções sobre a Lipina na DM1. A espectroscopia FTIR é uma ferramenta valiosa para caracterizar doentes com diferentes severidades da DM1, o que é crucial para um diagnóstico adequado e para estudos futuros. Reunimos com sucesso as medidas mais consensuais e importantes para avaliar a força muscular. Os resultados obtidos foram importantes e úteis, pois serão valiosos para avaliação da força muscular em futuros ensaios clínicos e estudos observacionais, principalm
Mestrado em Biologia Molecular e Celular